Lithuania’s Biomatter Raises €16.2M Series A to Design Enzymes Not Found in Nature
Vilnius-based Biomatter has raised €16.2M ($18M) in a Series A led by Astanor. The money will go into a new enzyme design and testing facility in Vilnius and a bigger push into the US.